<DOC>
	<DOCNO>NCT00712712</DOCNO>
	<brief_summary>RATIONALE : Morphine may reduce pain patient undergone radiofrequency ablation remove bone metastasis . PURPOSE : This phase II trial study well morphine work radiofrequency ablation painful bone metastases patient cancer .</brief_summary>
	<brief_title>Morphine After Radiofrequency Ablation Painful Bone Metastases Patients With Cancer</brief_title>
	<detailed_description>OBJECTIVES : Primary - Measure efficacy morphine sulfate 8 week radiofrequency ablation ( RFA ) bone metastasis . Secondary - Assess minimum average pain analyze use morphine sulfate RFA . - Determine disease progression CT scan bone . - Evaluate percentage relief associate RFA , specifically patient satisfaction , quality life , anxiety , depression , physical performance RFA . - Assess complication side effect relate RFA evolution possible side effect associate morphine sulfate therapy . OUTLINE : This multicenter study . Patients complete pain questionnaire 1 week undergoing radiofrequency ablation ( RFA ) . Patients also complete questionnaire pain , physical performance , quality life ( QOL ) , anxiety baseline . Bone metastases remove radiofrequency ablation ( RFA ) . After surgery , patient receive acetaminophen patient-controlled analgesic ( PCA ) morphine sulfate . PCA morphine sulfate continue dose increase 50 % bolus every 24 hour . Patients maximum pain less equal inclusion receive standard morphine sulfate therapy instead . Data concern total dose PCA morphine sulfate ; minimum , average , maximum pain intensity ; side effect complication RFA ; total dose morphine sulfate ( equivalent ) collect daily . Pain assess 4 8 week RFA . Patients complete follow-up questionnaire physical performance , QOL , anxiety 12 week . Patients also undergo CT scan 12 week .</detailed_description>
	<mesh_term>Neoplasm Metastasis</mesh_term>
	<mesh_term>Morphine</mesh_term>
	<mesh_term>Acetaminophen</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically confirm cancer Primary unknown origin Painful bone metastases despite radiotherapy symptomatic relapse previously irradiate area possibility repeat radiotherapy Bone metastases may treat bisphosphonates Osteolytic bone joint ( lytic condense ) confirm CT scan meeting follow criterion : Lesion size ≤ 5 cm No 2 painful bone metastasis If 2 lesion treat , distinct anatomical location treat time Metastatic bone lesion pelvis , sacrum ( absence canal involvement ) , rib , long bone allow Pain located tumor area Maximum pain last 24 hour &gt; 4 point ( numerical scale 11 point ) PATIENT CHARACTERISTICS : Life expectancy &gt; 3 month Platelet count &gt; 50,000/μL Prothrombin &lt; 50 % Activated cephalin time ≤ 1.5 time normal Not pregnant Fertile patient must use effective contraception No geographical , social , psychiatric reason would preclude follow PRIOR CONCURRENT THERAPY : See Disease Characteristics At least 4 week since prior radiotherapy At least 3 week since prior chemotherapy bisphosphonates At least 1 week since begin new painkiller therapy anticoagulation treatment More 30 day since participation another drug study More 30 day since prior surgery</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>July 2009</verification_date>
	<keyword>bone metastasis</keyword>
	<keyword>unspecified adult solid tumor , protocol specific</keyword>
	<keyword>pain</keyword>
</DOC>